What You Should Know:
– Method AI, a medical technology company focused on improving oncology outcomes secures $20M in Series A funding led by a private family office, with participation from Cleveland Clinic and JobsOhio…
Continue Reading
What You Should Know:
– San Francisco-based Citizen Health, a platform empowering patients with rare and complex conditions, secures $30M in Series A funding led by 8VC, with participation from Transformation Capital and Headline, bringing…
Continue Reading
What You Should Know:
– Isaac Health, a leading health technology company for brain health and dementia care, announced today a $10.5 million Series A led by Flare Capital Partners, with participation from new investors, Industry…
Continue Reading
What You Should Know:
– Arintra, the leading GenAI-native autonomous medical coding platform for healthcare providers, has raised $21 million in Series A funding.
– The round was led by Peak XV with participation from Endeavor Health Ventures,…
Continue Reading
Founded in 2014, MAGENTIQ-EYE offers a groundbreaking AI-aided colonoscopy solution that offers one of the best performances known today. With worldwide recognition from the gastroenterology community, and dozens of procedures performed every day with…
Continue Reading
What You Should Know:
– C8 Health, a best practices implementation platform for healthcare, today announced a $12M Series A funding round led by Team8, with participation from 10D and Vertex Ventures Israel. The latest…
Continue Reading
What You Should Know:
– Slingshot AI announced the public launch of Ash, the first AI designed for therapy, alongside an extension of its Series A funding round. Co-led by Radical Ventures and Forerunner Ventures,…
Continue Reading
What You Should Know:
– Charta Health, an AI-powered platform that automates and optimizes medical billing and clinical documentation workflows secures $22M in Series A funding round led by Bain Capital Ventures, with participation from…
Continue Reading
What You Should Know:
– OpenEvidence, the most widely used medical search and AI application among verified U.S. clinicians raises $210M in Series B funding round, valuing the company at $3.5 billion. The round was…
Continue Reading
What You Should Know:
– Centivax, a biotech company developing durable, universal vaccines, today announced the close of a $45 million Series A led by Steve Jurvetson’s Future Ventures, with participation from NFX, BOLD Capital, Base4,…
Continue Reading
